z-logo
open-access-imgOpen Access
Comparative characteristics of the level of highly sensitive C-reactive protein in patients with systemic lupus erythematosus and rheumatoid arthritis
Author(s) -
Ю. Р. Ахвердян,
Б. В. Заводовский,
Ю. В. Полякова,
Л. Е. Сивордова,
E. Papichev
Publication year - 2021
Publication title -
sibirskij naučnyj medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2410-2520
pISSN - 2410-2512
DOI - 10.18699/ssmj20210409
Subject(s) - medicine , microalbuminuria , rheumatoid arthritis , anti nuclear antibody , rheumatoid factor , c reactive protein , gastroenterology , lupus erythematosus , acute phase protein , arthritis , immunology , urine , antibody , autoantibody , inflammation , disease
The aim of this work was to study the dependence of the concentration of C-reactive protein in the blood of patients on the severity of systemic lupus erythematosus (SLE). Material and methods . We examined 26 patients with SLE, the comparison group consisted of patients with rheumatoid arthritis (RA) ( n = 88). Results . The hsCRP level was significantly higher in patients with a high degree of activity than in patients with minimal and moderate SLE activity ( F = 4.409, p = 0.023). In addition, in patients with SLE, a significant direct correlation was found between hsCRP and ESR values ( r = 0.409, p = 0.047), antinuclear factor ( r = 0.389, p = 0.021), antibodies to double-stranded DNA ( r = 0.226, p = 0.033), leukocytes in urine ( r = 0.571, p = 0.002), microalbuminuria ( r = 0.727, p = 0.017) AsAT ( r = 0.428,  p = 0.046), and inverse correlation – with the value of blood leukocytes ( r = –0.662, p < 0.001). Conclusion . It was found that an increase in the levels of hsCRP in the sera of SLE patients is accompanied by an increase in the degree of disease activity, which indicates a direct correlation between the level of hsCRP and SLE activity. Consequently, the concentration of hsCRP reflects the acute phase response and the intensity of the inflammatory process in SLE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here